(Reuters) - Accelerated battery depletion was found in 19 of about 73,000 devices, the company said.
Boston Scientific bought Guidant last year for $27 billion to acquire its portfolio of devices used to control and restore heart rhythms, including its implantable cardioverter defibrillators, or ICDs. But high-profile recalls of some of the devices have depressed sales.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment